Charles Schwab Investment Management Inc Verve Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 572,173 shares of VERV stock, worth $3.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

572,173

Previous 446,063 28.27%

Holding current value

$3.3 Million

Previous $2.18 Million 27.25%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$4.4 - $7.86 $554,884 - $991,224	126,110 Added 28.27%	572,173 $2.77 Million
Q2 2024 Aug 12, 2024	SELL	$4.76 - $12.79 $194,893 - $523,673	-40,944 Reduced 8.41%	446,063 $2.18 Million
Q1 2024 May 08, 2024	BUY	$10.81 - $17.96 $1.27 Million - $2.11 Million	117,337 Added 31.74%	487,007 $6.47 Million
Q4 2023 Feb 06, 2024	BUY	$8.84 - $18.7 $58,573 - $123,906	6,626 Added 1.83%	369,670 $5.15 Million
Q3 2023 Nov 08, 2023	BUY	$11.42 - $20.82 $315,249 - $574,736	27,605 Added 8.23%	363,044 $4.81 Million
Q2 2023 Aug 09, 2023	BUY	$13.34 - $19.9 $175,274 - $261,466	13,139 Added 4.08%	335,439 $6.29 Million
Q1 2023 May 11, 2023	BUY	$14.3 - $24.01 $24,638 - $41,369	1,723 Added 0.54%	322,300 $4.65 Million
Q4 2022 Feb 13, 2023	BUY	$17.85 - $40.7 $244,973 - $558,566	13,724 Added 4.47%	320,577 $6.2 Million
Q3 2022 Nov 14, 2022	BUY	$15.63 - $41.49 $2.53 Million - $6.72 Million	161,963 Added 111.78%	306,853 $10.5 Million
Q2 2022 Aug 15, 2022	SELL	$11.14 - $23.17 $96,472 - $200,652	-8,660 Reduced 5.64%	144,890 $2.21 Million
Q1 2022 May 13, 2022	BUY	$20.92 - $39.36 $1.02 Million - $1.92 Million	48,824 Added 46.62%	153,550 $3.51 Million
Q4 2021 Feb 11, 2022	BUY	$31.94 - $54.82 $61,197 - $105,035	1,916 Added 1.86%	104,726 $3.86 Million
Q3 2021 Nov 16, 2021	BUY	$46.0 - $73.99 $4.73 Million - $7.61 Million	102,810 New	102,810 $4.83 Million

Others Institutions Holding VERV

# of Institutions

186

Shares Held

73.3M

Call Options Held

85K

Put Options Held

215K

View Full List

About Verve Therapeutics, Inc.

Ticker VERV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,942,300
Market Cap $346M
Description
Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...

More about VERV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Verve Therapeutics, Inc. Transaction History